SEC Filings

Filing date	Form	Description	View
07/13/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-079571.pdf 0001104659-22-079571.rtf 0001104659-22-079571.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
07/13/22	SC TO-C	Written public communication relating to an issuer or third party tender offer	View HTML 0001104659-22-079572.pdf 0001104659-22-079572.rtf 0001104659-22-079572.xls
06/16/22	SC 13G	A statement of beneficial ownership of common stock by certain persons	View HTML 0001357550-22-000103.pdf 0001357550-22-000103.rtf
05/24/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-005627.pdf 0001415889-22-005627.rtf 0001415889-22-005627.xls
05/24/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-005629.pdf 0001415889-22-005629.rtf 0001415889-22-005629.xls
05/24/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-005631.pdf 0001415889-22-005631.rtf 0001415889-22-005631.xls
05/24/22	4	Statement of changes in beneficial ownership of securities	View HTML 0001415889-22-005633.pdf 0001415889-22-005633.rtf 0001415889-22-005633.xls
05/06/22	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001558370-22-007651.pdf 0001558370-22-007651.rtf 0001558370-22-007651.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
05/05/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-056472.pdf 0001104659-22-056472.rtf 0001104659-22-056472.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
04/28/22	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-22-052332.pdf 0001104659-22-052332.rtf 0001104659-22-052332.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.